According to the latest cash accounts they have 6.8 quarters at current rates. this includes loan's facilities that are in place. I don't see why a capital raise would be required for what appears a small (certainly in numbers) trial. More revenue from existing products would be nice though???
Ann: Update on BLA for Graft Versus Host Disease, page-680
-
- There are more pages in this discussion • 338 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.000(0.00%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | $1.01 | $503.2K | 498.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 11827 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 59245 | 16 |
View Market Depth
| Last trade - 10.57am 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |